Blog Search
Archive
Blog Statistics
  • Views: 3643920
  • Articles: 1366
  • Comments: 1027
  • Status: Public
  • Who's Viewing: 5
  • Guest
  • Guest
  • Guest
  • Guest
  • Guest
5 Guests  0 Members
Posted by bio_man   March 7, 2018   2064 views
A promising new drug called baloxavir marboxil (Xofluza) developed in Japan has been shown to stop the flu virus from spreading 24 hours after intake.

The drug interferes with influenza A and influenza B's main replication process instead of inhibiting the neuraminidase enzyme, as accomplished by previous drugs such as oseltamivir (Tamiflu) and zanamivir (Relenza). As shown in the illustration, viral neuraminidase sits on the surface of influenza viruses and enables it to be released once reproduced within the infected host cell.

Xofluza accomplishes its mode of action by inhibiting the cap-dependent endonuclease activity of the viral polymerase. It achieves this by inhibiting the process known as cap snatching, which is a mechanism exploited by viruses to hijack the host mRNA transcription system to allow synthesis of viral RNAs.

Data from the drug maker shows that although Xofluza works days faster than Tamiflu in stopping the flu virus, symptoms begin to recede at the same time under both medications. The drug has been approved for sale in Japan as of February 23, 2018.

Source http://www.ppdictionary.com/viruses/flu_a.htm

enzyme drug influenza Japan Asia
Posted in Research
You might also like...
No Comments | Write Comment
Random Article
   RSS Feed     Atom Feed     RDF Feed